Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

about

Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway.

P2860

Q47386296-AB26A83C-FF2D-49B8-8E37-52167B1B4C7F

P2860

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Item

http://www.wikidata.org/entity/Q47879810

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

@en

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

@nl

type

Item

label

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

@en

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

@nl

prefLabel

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

@en

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

@nl

P1476

Secretogranin III: a diabetic retinopathy-selective angiogenic factor

@en

P2093

Hong Tian

http://www.w3.org/2001/XMLSchema#string

Keith A Webster

http://www.w3.org/2001/XMLSchema#string

Michelle E LeBlanc

http://www.w3.org/2001/XMLSchema#string

P2860

Origins, actions and dynamic expression patterns of the neuropeptide VGF in rat peripheral and central sensory neurones following peripheral nerve injury

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo

CCR3 is a target for age-related macular degeneration diagnosis and therapy

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells

The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus

Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy

Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice

The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism

P2888

s00018-017-2635-5

P304

635-647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-017-2635-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Li

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28856381

http://www.w3.org/2001/XMLSchema#string

P932

5771826

http://www.w3.org/2001/XMLSchema#string

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

about

P2860

P2860

Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932